About

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Medical Information aims to empower the healthcare community to make informed decisions about our medicines, enabling better outcomes for patients.

Address

3 Rue Joseph Monier
BP 325 - 92506 Rueil-Malmaison
Cedex
France

Contact details

Medical Information phone number
+33-1-58 83 84 96

Hours of operation
24/7

Medical Information website
https://www.bmsmedinfo.fr/

Medical Information email
infomed@bms.com

Click to chat
https://www.bmsmedinfo.fr/

Adverse events and product complaints

Please use the contact details below to provide adverse events or product complaints

Adverse event phone number
+33-1-58 83 84 96

Adverse event email
infomed@bms.com

Submit medical inquiry
https://www.bmsmedinfo.fr/emirf_fr

Company website
https://www.bms.com/fr

BMS products

Medicinal products marked withare subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

AXEPIM®
(céfépime)

BARACLUDE®
(entecavir)

COUMADINE®
(warfarine)

DAKLINZA®
(daclatasvir)

ECAZIDE®
(captopril, hydrochlorothiazide)

ELIQUIS®
(apixaban)

ELISOR®
(pravastatine)

ETOPOPHOS®
(étoposide)

FUNGIZONE®
(amphotéricine B)

HYDREA®
(hydroxycarbamide)

KENACORT RETARD®
(acétonide de triamcinolone)

LOPRIL®
(captopril)

NULOJIX®
(bélatacept)

OPDIVO®
(nivolumab)

ORACEFAL®
(céfadroxil)

ORENCIA®
(abatacept)

PERFALGAN®
(paracétamol)

QUESTRAN®
(colestyramine)

REVIA®
(naltrexone)

REYATAZ®
(atazanavir)

SPRYCEL®
(dasatinib)

SUSTIVA®
(efavirenz)

YERVOY®
(ipilimumab)

ZERIT®
(stavudine)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Last updated: 10/03/2020